drugset

drugset / Trial / NCT00626652

Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation

NCT00626652 ↗

Phase 2 Completed 153 enrolled Sequel Pharmaceuticals, Inc

RandomizedSingle-groupQuadruple-blindTreatment

Summary

To evaluate the effects of K201 on sinus rhythm restoration, symptom score, various cardiovascular parameters, and safety.

Timeline

Start: 2008-03
Primary completion: 2009-12
Completion: 2009-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	K201	Unknown	—	Intravenous

Indications